Clinical Trial Feasibility Survey and Recruitment Support (AMED)
NoticeJapanese title: 治験フィージビリティ調査・リクルート支援対応(AMED) 一式
Overview
National Cancer Center Japan (NCC) is procuring a comprehensive service for clinical trial feasibility surveys and recruitment support under the AMED framework. The contract includes all related costs such as equipment, materials, and operational expenses. Performance period and location are specified in the tender documents, with execution at the NCC East Hospital.
Key Details
- Source: KKJ
- Notice type: Notice
- Publication date: October 7, 2026
- Procuring entity: National Cancer Center Japan (NCC)
- Submission deadline: October 29, 2026, 17:00 JST
- Bid opening: October 30, 2026, 11:20 JST
- Award method: Lowest-price award
- Eligibility (from notice): All-ministry unified qualification, 'services', grade A–D, Kanto-Koshinetsu region – verify in the tender documents
- Status: Active
- Technology relevance: Possible
- Business-action likelihood: Medium – Open competitive bidding with clear qualification criteria but requires compliance with NCC regulations and local social insurance enrollment, which may pose moderate barriers.
Official Notice
Official Source
KKJ, Japan's Government Procurement Information Website, which aggregates procurement notices from national and local public-sector organizations.
- Source: KKJ (Government Procurement Information Website)
- Official category: Open competitive tender
- Publication date: October 7, 2026
- Publication: Official notice document (PDF)
Full English Translation
The following English translation was prepared from the original Japanese notice published by the procuring entity and listed on KKJ, Japan's Government Procurement Information Website. The translation below is based on the Japanese source text.
The following is subject to open competitive bidding.
October 7, 2026
National Cancer Center Japan
Director of National Cancer Center East Hospital, Toshihiko Doi
Procurement Agency Number 819
Location Number 12
1 Procurement Details
(1) Procurement Subject and Quantity
Clinical Trial Feasibility Survey and Recruitment Support (AMED) One Set
(2) Characteristics of Procurement Subject
According to the tender documents and specifications.
(3) Performance Deadline
According to the tender documents and specifications.
(4) Performance Location
National Cancer Center Japan East Hospital
(5) Bidding Method
The selection of the negotiation rights holder will be conducted by the lowest price method,
① The bidder must submit a bid including all direct expenses related to the procurement subject, as well as all incidental expenses such as equipment, materials, machinery, transportation costs, and outsourcing fees.
② In determining the negotiation rights holder, the bid amount will be increased by 10% of the stated amount (any fraction less than one yen will be truncated), and this increased amount will be considered the application amount. Bidders must submit a bid stating 100/110 of the estimated contract amount regardless of whether they are taxable or tax-exempt entities for consumption tax and local consumption tax.
2 Eligibility for Participation
(1) Must not fall under the provisions of Article 6 of the National Cancer Center Japan Contract Handling Regulations. Minors, persons under guardianship or assistance who have obtained necessary consent for contract conclusion may be exceptions.
(2) Must not fall under the provisions of Article 7 of the National Cancer Center Japan Contract Handling Regulations.
(3) Must be rated A, B, C, or D in the qualification examination notification (unified participation qualification for all ministries and agencies) for 'Provision of Services' and have competitive participation qualifications in the Kanto-Koshinetsu region.
(4) Must be enrolled in social insurance systems (welfare pension insurance, health insurance managed by the Japan Health Insurance Association, seamen's insurance, national pension, workers' accident compensation insurance, and employment insurance) and have no arrears in insurance premiums for the past two years.
3 Submission Location of Bid Documents, etc.
(1) Place for submission of bid documents and contract terms
Place for distribution of tender documents and inquiries:
6-5-1 Kashiwanoha, Kashiwa City, Chiba Prefecture 277-8577
National Cancer Center Japan East Hospital
Kashiwa C Finance and Accounting Section, Research Operations
Phone: 04-7130-0222 ext. 2375
(2) Method of distribution of tender documents
Distributed at the place in (1).
(3) Deadline for receipt of bid documents
October 29, 2026, 17:00
(4) Date and place of bid opening
October 30, 2026, 11:20
National Cancer Center Japan East Hospital, 3rd Floor, 2nd Conference Room
4 Others
(1) Language and currency used in contract procedures
Japanese and Japanese currency
(2) Bid and contract guarantee deposits
Exempted
(3) Requirements for bidders
Bidders wishing to participate in this open competition must submit sealed bid documents with proof of ability to perform the work by the deadline. Bidders must respond to explanations requested by the contract officer before the bid opening date.
(4) Invalid bids
Bids submitted by those not qualified or who fail to fulfill obligations will be invalid.
(5) Necessity of contract document
Required
(6) Method of contractor selection
Among bidders who submit bid documents with attached documents/materials and meet all qualification and specification requirements, the one with the lowest price within the estimated price limit set by Articles 37 and 38 of the NCC Contract Handling Regulations will be selected as the negotiation rights holder and contract negotiation partner.
(7) Details are according to the tender documents.
Show original Japanese notice
入札公告
次のとおり一般競争入札に付します。令和8年10月7日国立研究開発法人国立がん研究センター東病院長土井俊彦◎調達機関番号819 ◎所在地番号121 調達内容(1)調達件名及び数量治験フィージビリティ調査・リクルート支援対応(AMED) 一式(2)調達件名の特質等入札説明書及び仕様書による。 (3) 履行期限入札説明書及び仕様書による。 (4) 履行場所 国立研究開発法人国立がん研究センター東病院(5)入札方法交渉権者の決定は、最低価格方式をもって行うので、① 入札者が提出する入札書は、調達件名にかかる直接経費の他、機材、資材、機械器具、運搬費、業務委託に要する費用等、一切の諸経費を含め、契約金額を見積もるものとする。② 交渉権者決定にあたっては、入札書に記載された金額に当該金額の10%に相当する額を加算した金額(当該金額に1円未満の端数がある場合は、その端数金額を切り捨てた金額とする。)をもって申込金額とするので、入札者は、消費税及び地方消費税に係る課税事業者であるか免税事業者であるかを問わず、見積もった契約金額の110分の100に相当する金額を記載した入札書を提出しなければならない。2 競争参加資格(1)国立研究開発法人国立がん研究センター契約事務取扱細則第6条の規定に該当しない者であること。なお、未成年者、被保佐人又は被補助人であっても、契約締結のために必要な同意を得ている者は、同条中、特別の理由がある場合に該当する。(2)国立研究開発法人国立がん研究センター契約事務取扱細則第7条の規定に該当しない者であること。(3)資格審査結果通知書(全省庁統一参加資格)「役務の提供等」で「A」、「B」、「C」又は「D」等級に格付けされ、関東・甲信越地域の競争参加資格を有する者であること。(4)社会保険等(厚生年金保険、健康保険(全国健康保険協会が管掌するもの)、船員保険、国民年金、労働者災害補償保険及び雇用保険をいう。)に加入し、該当する制度の保険料の滞納がないこと。(直近2年間の社会保険料及び労働保険料の未納がないこと。)3 入札書の提出場所等(1)入札書の提出場所、契約条項を示す場所入札説明書の交付場所及び問い合わせ先〒277-8577 千葉県柏市柏の葉6-5-1国立研究開発法人国立がん研究センター東病院柏C財務経理課研究業務係電話04-7130-0222内線2375(2)入札説明書の交付方法 (1)の交付場所にて交付する。(3)入札書の受領期限令和8年10月29日17時00分 (4) 開札の日時及び場所令和8年10月30日11時20分~国立研究開発法人国立がん研究センター東病院病院棟3階第二会議室4 その他(1)契約手続において使用する言語及び通貨日本語及び日本国通貨(2)入札保証金及び契約保証金 免除(3)入札者に要求される事項この一般競争に参加を希望する者は、封印した入札書に本公告に示した業務が履行できることを証明する書類を添付して入札書の受領期限までに提出しなければならない。入札者は、開札日の前日までの間において、契約担当者等から当該書類に関し説明を求められた場合には、これに応じなければならない。(4)入札の無効本公告に示した競争参加資格のない者の提出した入札書、入札者に求められる義務を履行しなかった者の提出した入札書は無効とする。(5)契約書作成の要否 要(6)契約者の決定方法本公告及び入札説明書に従い、書類・資料を添付した入札書を提出した入札者であって、本入札公告及び入札説明書の競争参加資格及び仕様書の要求、要件を全て満たし、当該入札者の入札書が国立研究開発法人国立がん研究センター契約事務取扱細則第37条及び38条の規定に基づいて作成された予定価格の制限の範囲内であり、かつ、最低の価格をもって入札を行った者を交渉権者とし、契約交渉の相手方とする。(7)詳細は入札説明書による。
Business Signal
Business Relevance
Potential relevance requires a targeted fit check. Confirm the supplier's documented capabilities against the actual requirements and verify a participation route.
- Product fit: Potential
- Current-case feasibility: Unknown
- Evidence confidence: Low
- Supply-chain security: Unknown
Earliest required deadline in the examined route (Japan time): 2026-10-29T17:00:00+09:00
Participation fit
Participation is expected to require appropriate Japanese government procurement eligibility, or cooperation with a suitable Japanese partner holding the required qualification. The eligibility requirements have not been fully reviewed and should be verified against the official tender documents.
This page is based on the official procurement notice published by the procuring entity and listed on KKJ, Japan's Government Procurement Information Website, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.
JBid is a beta technology-procurement intelligence service by I.J. Do.